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Supplementary Figure 1. Mouse iPS cell colonies 
generated in the absence of VPA before (left) and after 
(right) trypsinization and replating the cells. Top, 
brightfield; bottom, GFP fluorescence. 
Supplementary Figure 2. Immunocytochemical characterization of human iPS cells generated by Sleeping Beauty transposon-
mediated reprogramming. A typical iPS clump was examined by confocal microscopy after staining with antibodies against pluriopotency 
markers: Oct4 and Nanog (DAPI- blue, Oct4- green, Nanog- red) (A), SSEA4 (B) and podocalyxin (C). FACS analyses showed that iPS cells are 
positive for SSEA4 (D) and podocalyxin (E). For FACS images, median values and gated percentages are presented. IK in parantheses stands 
for the median isotype control.  
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Supplementary Figure 3. Immunocytochemical characterization of human iPS cells generated by Sleeping 
Beauty transposon-mediated reprogramming. In comparison with HFF cells, human iPS cells showed decreased 
expression of CD44 and CD73 markers that are characteristic to more differentiated cellular phenotypes. Median values 
and gated percentages are presented. IK in parantheses stands for the median isotype control. 
Supplementary Figure 4. Heatmap of expression profiles of 
pluripotency-associated genes in four different human iPS cell clones, 
in the human ES cell line HUES6 and in HFFs.  
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Supplementary Figure 5. COBRA-FISH analysis of human iPS and parental HFF cells. Slides with metaphase 
chromosomes were hybridized using multicolor COBRA-FISH. 48-color FISH staining every chromosome arm in a 
different color combination, digital imaging and analysis was performed as previously described (Szuhai & Tanke, Nature 
Protocols, 2006). 
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Supplementary Figure 6. Silencing of transgenes in stable human iPS cells. (A) Transgene-specific PCR primers permit 
determination of relative expression levels between endogenous (endo) OCT4, SOX2, MYC and KLF4 genes and SB-expressed 
(Tg Sox2-2A-Klf4) transgenes via qRT-PCR. HFF cells transfected with the SB-based reprogramming vector (HFF-transfected) 
served as an early time-point sample. (B) The SB integration locus is transcriptionally active in pre-iPS colonies, and express 
mCherry. In stable human iPS cell lines, mCherry is silenced, but can be reactivated by 5-Aza-2'-Deoxycytidine (5-Aza).  
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Supplementary Figure 7. mRNA expression analysis of specific differentiation markers. Differentiation assays were carried out by 
generating EBs for 6 days (EB day 1-6). Six days later EBs were placed onto gelatin-coated plates. The attached cells differentiated 
spontaneously, the differentiation process being followed for up to 14 additional days, with mRNA harvests at days 3, 7, 11, 14 (day 6+3, day 
6+7, day 6+11, day 6+14). For gene expression analysis quantitative real-time PCR was carried out on cDNAs obtained after total RNA 
extraction and reverse transcription. HFFs were negative for Nanog (A), Oct4 (B) and Pax6 (C) and positive for CAPG (D). After 
reprogramming, iPS cells (clone 5, obtained with 5 factors, 5F C5) expressed Oct4 and Nanog, whose expression declined during 
differentiation. Differentiating cells acquired Pax6 expression during the late stages of differentiation, probably in parallel with the appearance 
of neuron-like cells. CAPG expression characteristic to skin cells showed a high expression level in the initial HFFs, and its expression 
declined in iPS or differentiated cells. 
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Supplementary Figure 8. Generation of mouse iPS cells with pT2-OSKML and pT2-OSKM-mir302/367 vectors. 5X105 mouse OG2 
cells were electroporated with 500ng of either pT2-OSKML or pT2-OSKM-miR302/367 transposon- and 50ng of SB100X transposase 
vectors. After electroporation, cells were seeded to one geltrex-coated well of a 6-well plate and grown in mouse iPS medium in the 
absence of valproic acid. OG2 cells electroporated with the pT2-OSKML vector formed typical pre-iPS colonies described before and, at a 
later stage, typical mouse ES-like iPS colonies, which started to express GFP fluorescence together with the appearence of clump-like 
patches in the pre-iPS colonies. In contrast, OG2 cells electroporated with pT2-OSKM-miR302/367 retained a “flat” morphology all the 
way through the reprogramming process, generating distinctive iPS “nests” and pre-iPS colonies, which at a later stage formed GFP 
positive clones with a “flat” morphology reminescent of epiblast-derived stem cells (EpiSCs).  
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Supplementary Figure 9. Chromosomal mapping of Sleeping Beauty transposon insertion in the mouse genome. The SB 
transposon was integrated into a TA site on chromosome X, and there are no known protein coding and miRNA genes in a window of ±20 
kb around the transposon insertion site.  
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Primers used in this study 
 Gene Primer Sequence 
Amplicon 
length 
BfaI linker 
(+) 
GTAATACGACTCACTATAGGGCTCCGCTTAAGGGAC  
Splinkerette 
linker MboI linker 
(-) 
p-GATCGTCCCTTAAGCGGAG-amino  
linker GTAATACGACTCACTATAGGGC  
Tbal rev3 CATGACATCATTTTCTGGA ATT  
Tbal CTTGTGTCATGCACAAAGTAGATGTCC  
Nested PCR 
nested AGGGCTCCGCTTAAGGGAC  
forward GCA ACGGCAGCTACAGCATGATGCAG Sox2-Klf4 
junction reverse CAGGAGGTCGTTGAACTCCTCGGTCTC 
800 bp 
forward TGACTGTGCCTTTAAACAGCTTGGA SB-mCherry 
junction reverse GCGTGGTGACCGTGACCCAG 
980 bp 
Sox2-2A-Klf4 forward CCCGCTGCGCCCAGTAGAC 
Sox2-2A-Klf4 reverse AGAAGGACGGGAGCAGAGCGT 
202 bp 
forward GGATGCTGTGAGCCAAGG 
Oct4 
reverse GAACAAAATGATGAGTGACAGACAG 
175 bp 
forward TTCTTGCTTACAAGGGTCTGC 
Nanog 
reverse CAGGGCTGCCTTGAAGAG 
95 bp 
forward GGCAGAGAAGAGAGTGTTTGC 
Sox2 
reverse TCTTCTTTCTCCCAGCCCTA 
76 bp 
forward TCTTCTCTCAATAGAGTGAGTGTGC 
Rex1 
reverse GCTTTCTTCTGTGTGCAGGA 
60 bp 
forward TCGACTTGGTGATTGGTGGAA 
Dnmt3b 
reverse TTTGCGGGCAGGATTGAC 
62 bp 
forward GGGTGTTCGTGGGAACCT 
Gdf3 
reverse CCATCTTGGAAAGGTTTCTGTG 
78 bp 
forward CCAACAACTACAACGCCTACGA 
Fgf4 
reverse TTCTTACTGAGGGCCATGAACA 
64 bp 
forward CACTTTGTGTTCAGGACCTCAG 
Ncam1 
reverse AAAAGCAATGAGACCAAGGTG 
92 bp 
forward TTTCTTTCCTGTGGTTCTGC 
Sox1 
reverse GACTCTGTGGTGGTGAGGTC 
227 bp 
forward ACAGAGTTCTTCGCAACCTG 
Pax6 
reverse CATCTGAGCTTCATCCGAGT 
236 bp 
M
ouse iP
S
 cells 
forward AGCACAGTCTCTTCGCTGCT 
 
Zic1 
reverse GCTCGTGAAGCCCAGAAA 
96 bp 
forward TGCTGCAAATTACCCATGAT 
Afp 
reverse AAGGTTGGGGTGAGTTCTTG 
192 bp 
forward GGTCTCTACAGCAAGATGAATGG 
Gata6 
reverse TGGCACAGGACAGTCCAAG 
94 bp 
forward CACAACGCAGAGCTAAGCAA 
Sox17 
reverse CGCTTCTCTGCCAAGGTC 
65 bp 
forward AAATAATGTAAGAGTCTGGTGTACCG 
Foxa2 
reverse CCATGTCCAGAATGGGATGT 
68 bp 
forward ACCGGCACCAAACTGAGAT 
Eomes 
reverse AAGCTCAAGAAAGGAAACATGC 
64 bp 
forward CGAAAGGAAGAGCCTGGAC 
Lmo2 
reverse AGCGGTCCCCTATGTTCTG 
107 bp 
forward AAGGCTGGGTGAAGACCCTTA 
Cd34 
reverse TGAATGGCCGTTTCTGGAAGT 
157 bp 
forward CAGCCCACCTACTGGCTCTA 
T 
reverse GAGCCTGGGGTGATGGTA 
72 bp 
forward GTGTTCCTACCCCCAATGTGT 
 
Gapdh 
reverse ATTGTCATACCAGGAAATGAGCTT 
248 bp 
forward CGACCATCTGCCGCTTTG 
OCT4 
reverse GCCGCAGCTTACACATGTTCT 
60 bp 
forward ACAGCA AATGACAGCTGCAAA 
SOX2 
reverse TCGGCATCGCGGTTTTT 
68 bp 
forward CCA AAGGCA AACAACCCACTT 
NANOG 
reverse CGGGACCTTGTCTTCCTTTTT 
62 bp 
forward AGTACCCCGGCATGTTCATC 
FGF4 
reverse CGGTTCCCCTTCTTGGTCTT 
58 bp 
forward GGGAGAAGACACTGCGTCA KLF4 
reverse GGAAGCACTGGGGGAAGT 
88 bp 
forward CACCAGCAGCGACTCTGA 
MYC 
reverse GATCCAGACTCTGACCTTTTGC 
102 bp 
forward CGGAGACCACGTTTCAAA AGA 
TERT 
reverse TTTGCAACTTGCTCCAGACAC T 
66 bp 
forward TCGCTGAGCTGAAACAAATG 
REX1 
reverse CCCTTCTTGAAGGTTTACAC 
170 bp 
forward CGGTGTTTCTGTGTGGAGTG 
DNMT3B 
reverse CGCACGTTCCAGTCCTTC 
146 bp 
forward GGTGCCAGTTAAAGATGACGC 
DPPA2 
reverse GAGGCAAAATGGTCGGCAAG 
188 bp 
forward GACCTCCACAGAGAAGTCGAG 145 bp 
H
um
an iP
S
 cells 
DPPA4 
reverse TGCCTTTTTCTTAGGGCAGAG  
forward AGCACATCAACTCGGAGGAG SALL4 
reverse CATTCCCTGGGTGGTTCACTG 
129 bp 
forward ATGGAAACTCTATTAAAGTGAACCTG 
NCAM 
reverse TAGACCTCATACTCAGCATTCCAGT 
178 bp 
forward GTCCATCTTTGCTTGGGAAA 
PAX6 
reverse TAGCCAGGTTGCGAAGAACT 
110 bp 
forward CTGGCTGTGGCAAGGTCTTC 
SOX1 
reverse CAGCCCTCAAACTCGCACTT 
97 bp 
forward GGCCAAGTTCTGGGAAGTCA 
TUBB3 
reverse CGAGTCGCCCACGTAGTTG 
70 bp 
forward CTGGCTGTGGCAAGGTCTTC 
ZIC1 
reverse CAGCCCTCAAACTCGCACTT 
97 bp 
forward AGCTTGGTGGTGGATGAAAC 
AFP 
reverse TCTGCAATGACAGCCTCAAG 
182 bp 
forward CGAGGAGATGCGTCCCATCAAGAC 
GATA4 
reverse AGTCCTGCTTGGAGCTGGTCTGTG 
203 bp 
forward GAGGGTGAACCCGTGTGCAATG 
GATA6 
reverse TGGAAGTTGGAGTCATGGGAATGG 
178 bp 
forward TGGGAGCGGTGAAGATGGAAGG 
FOXA2 
reverse CGTACGACGACATGTTCATGGAGC 
201 bp 
forward GCGCTTTGCTTGCTGAGT 
CD34 
reverse GGGTAGCAGTACCGTTGTTGT 
67 bp 
forward AGAGGGCTGTGCCTTCCGTTTC 
EOMES 
reverse AGCACACAGCAGAGGCCTAGCAAG 
213 bp 
forward ACTTCCTGAAGGCCATCGACCAG 
LMO2 
reverse CACCCGCATTGTCATCTCATAGGC 
209 bp 
forward ACCCAGTTCATAGCGGTGAC 
T 
reverse CCATTGGGAGTACCCAGGTT 
165 bp 
forward ATGGACGTGCTGGCCAAGGATG 
HAND1 
reverse TTAACTCCAGCGCCCAGACTTGC 
202 bp 
forward ATGGAA ATCCCATCACCATCTT 
 
GAPDH 
reverse CGCCCCACTTGATTTTGG 
60 bp 
forward GATTTTGTAGGTGGGATTAATTGTGAATTT 
Nanog_meth 
reverse ACCAAAAAAACCCACACTCATATCAATATA 
367 bp 
forward GGATGTTATTAAGATGAAGATAGTTGG 
OCT4_meth 
reverse CCTAAACTCCCCTTCAAAATCTATT 
406 bp 
forward TTATATTTTTGATTTAAAAGTTGGAAA 
bisulfite sequencing 
NANOG_meth 
reverse TAACATAAAACAACCAACTCAATCC 
306 bp 
 
 
Determination of transgene silencing in stable human iPS cells. First, transgene-specific 
primers against mouse Sox2 and Klf4 were designed to determine the expression of 
reprogramming transgenes in human stable iPS cells by qRT-PCR as well as HFFs transfected 
with SB-based reprogramming vectors. Data was normalized to GAPDH expression. Secondly, 
stable human iPS cells was treated with 5-Aza-2'-Deoxycytidine (5-Aza) for two days followed by 
checking mCherry expression under fluorescence microscope. 
 
